2.4.0.6 Html 282 340 1 false 78 0 false 7 false false R1.htm 001 - Document - Document And Entity Information Sheet http://www.interceptpharma.com/role/DocumentAndEntityInformation Document And Entity Information true false R2.htm 002 - Statement - Consolidated Balance Sheets Sheet http://www.interceptpharma.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets false false R3.htm 003 - Statement - Consolidated Balance Sheets [Parenthetical] Sheet http://www.interceptpharma.com/role/ConsolidatedBalanceSheetsparenthetical Consolidated Balance Sheets [Parenthetical] false false R4.htm 004 - Statement - Consolidated Statements of Operations and Comprehensive Loss Sheet http://www.interceptpharma.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveLoss Consolidated Statements of Operations and Comprehensive Loss false false R5.htm 005 - Statement - Consolidated Statements of Changes in Stockholders' Equity Sheet http://www.interceptpharma.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity Consolidated Statements of Changes in Stockholders' Equity false false R6.htm 006 - Statement - Consolidated Statements of Cash Flows Sheet http://www.interceptpharma.com/role/ConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows false false R7.htm 007 - Statement - Consolidated Statements of Cash Flows [Parenthetical] Sheet http://www.interceptpharma.com/role/ConsolidatedStatementsOfCashFlowsparenthetical Consolidated Statements of Cash Flows [Parenthetical] false false R8.htm 008 - Disclosure - Nature of Business Sheet http://www.interceptpharma.com/role/NatureOfBusiness Nature of Business false false R9.htm 009 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.interceptpharma.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies false false R10.htm 010 - Disclosure - Significant Agreements Sheet http://www.interceptpharma.com/role/SignificantAgreements Significant Agreements false false R11.htm 011 - Disclosure - Investments Sheet http://www.interceptpharma.com/role/Investments Investments false false R12.htm 012 - Disclosure - Prepaid Expenses and Other Current Assets Sheet http://www.interceptpharma.com/role/PrepaidExpensesAndOtherCurrentAssets Prepaid Expenses and Other Current Assets false false R13.htm 013 - Disclosure - Fixed Assets, Net Sheet http://www.interceptpharma.com/role/FixedAssetsNet Fixed Assets, Net false false R14.htm 014 - Disclosure - Accounts Payable, Accrued Expenses and Other Liabilities Sheet http://www.interceptpharma.com/role/AccountsPayableAccruedExpensesAndOtherLiabilities Accounts Payable, Accrued Expenses and Other Liabilities false false R15.htm 015 - Disclosure - Warrants to Purchase Common Stock Sheet http://www.interceptpharma.com/role/WarrantsToPurchaseCommonStock Warrants to Purchase Common Stock false false R16.htm 016 - Disclosure - Fair Value Measurements Sheet http://www.interceptpharma.com/role/FairValueMeasurements Fair Value Measurements false false R17.htm 017 - Disclosure - Stockholders' Equity and Preferred Stock Sheet http://www.interceptpharma.com/role/StockholdersEquityAndPreferredStock Stockholders' Equity and Preferred Stock false false R18.htm 018 - Disclosure - 2003 Stock Incentive Plan and 2012 Stock Plan Sheet http://www.interceptpharma.com/role/StockIncentivePlanAnd2012StockPlanCmToRevise 2003 Stock Incentive Plan and 2012 Stock Plan false false R19.htm 019 - Disclosure - QTDP Sheet http://www.interceptpharma.com/role/Qtdp QTDP false false R20.htm 020 - Disclosure - Commitment and Contingencies Sheet http://www.interceptpharma.com/role/CommitmentAndContingencies Commitment and Contingencies false false R21.htm 021 - Disclosure - Related Party Transactions Sheet http://www.interceptpharma.com/role/RelatedPartyTransactions Related Party Transactions false false R22.htm 022 - Disclosure - Net Loss Per Share Sheet http://www.interceptpharma.com/role/NetLossPerShare Net Loss Per Share false false R23.htm 023 - Disclosure - Quarterly Financial Data (unaudited) Sheet http://www.interceptpharma.com/role/QuarterlyFinancialDataUnaudited Quarterly Financial Data (unaudited) false false R24.htm 024 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.interceptpharma.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) false false R25.htm 025 - Disclosure - Investments (Tables) Sheet http://www.interceptpharma.com/role/InvestmentsTables Investments (Tables) false false R26.htm 026 - Disclosure - Prepaid Expenses and Other Current Assets (Tables) Sheet http://www.interceptpharma.com/role/PrepaidExpensesAndOtherCurrentAssetsTables Prepaid Expenses and Other Current Assets (Tables) false false R27.htm 027 - Disclosure - Fixed Assets, Net (Tables) Sheet http://www.interceptpharma.com/role/FixedAssetsNetTables Fixed Assets, Net (Tables) false false R28.htm 028 - Disclosure - Accounts Payable, Accrued Expenses and Other Liabilities (Tables) Sheet http://www.interceptpharma.com/role/AccountsPayableAccruedExpensesAndOtherLiabilitiesTables Accounts Payable, Accrued Expenses and Other Liabilities (Tables) false false R29.htm 029 - Disclosure - Warrants to Purchase Common Stock (Tables) Sheet http://www.interceptpharma.com/role/WarrantsToPurchaseCommonStockTables Warrants to Purchase Common Stock (Tables) false false R30.htm 030 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.interceptpharma.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) false false R31.htm 031 - Disclosure - 2003 Stock Incentive Plan and 2012 Stock Plan (Tables) Sheet http://www.interceptpharma.com/role/Stockincentiveplanand2012stockplancmtorevisetables 2003 Stock Incentive Plan and 2012 Stock Plan (Tables) false false R32.htm 032 - Disclosure - Commitment and Contingencies (Tables) Sheet http://www.interceptpharma.com/role/CommitmentAndContingenciesTables Commitment and Contingencies (Tables) false false R33.htm 033 - Disclosure - Net Loss Per Share (Tables) Sheet http://www.interceptpharma.com/role/NetLossPerShareTables Net Loss Per Share (Tables) false false R34.htm 034 - Disclosure - Quarterly Financial Data (unaudited) (Tables) Sheet http://www.interceptpharma.com/role/QuarterlyFinancialDataUnauditedTables Quarterly Financial Data (unaudited) (Tables) false false R35.htm 035 - Disclosure - Nature of Business (Details Textual) Sheet http://www.interceptpharma.com/role/NatureOfBusinessdetailstextual Nature of Business (Details Textual) false false R36.htm 036 - Disclosure - Summary of Significant Accounting Policies (Details Textual) Sheet http://www.interceptpharma.com/role/SummaryOfSignificantAccountingPoliciesDetailsTextual Summary of Significant Accounting Policies (Details Textual) false false R37.htm 037 - Disclosure - Significant Agreements (Details Textual) Sheet http://www.interceptpharma.com/role/SignificantAgreementsDetailsTextual Significant Agreements (Details Textual) false false R38.htm 038 - Disclosure - Investments (Details) Sheet http://www.interceptpharma.com/role/InvestmentsDetails Investments (Details) false false R39.htm 039 - Disclosure - Investments (Details 1) Sheet http://www.interceptpharma.com/role/InvestmentsDetails1 Investments (Details 1) false false R40.htm 040 - Disclosure - Prepaid Expenses and Other Current Assets (Details) Sheet http://www.interceptpharma.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails Prepaid Expenses and Other Current Assets (Details) false false R41.htm 041 - Disclosure - Fixed Assets, Net (Details) Sheet http://www.interceptpharma.com/role/FixedAssetsNetDetails Fixed Assets, Net (Details) false false R42.htm 042 - Disclosure - Fixed Assets, Net (Details Textual) Sheet http://www.interceptpharma.com/role/FixedAssetsNetDetailsTextual Fixed Assets, Net (Details Textual) false false R43.htm 043 - Disclosure - Accounts Payable, Accrued Expenses and Other Liabilities (Details) Sheet http://www.interceptpharma.com/role/AccountsPayableAccruedExpensesAndOtherLiabilitiesDetails Accounts Payable, Accrued Expenses and Other Liabilities (Details) false false R44.htm 044 - Disclosure - Warrants to Purchase Common Stock (Details) Sheet http://www.interceptpharma.com/role/WarrantsToPurchaseCommonStockDetails Warrants to Purchase Common Stock (Details) false false R45.htm 045 - Disclosure - Warrants to Purchase Common Stock (Details 1) Sheet http://www.interceptpharma.com/role/WarrantsToPurchaseCommonStockDetails1 Warrants to Purchase Common Stock (Details 1) false false R46.htm 046 - Disclosure - Fair Value Measurements (Details) Sheet http://www.interceptpharma.com/role/FairValueMeasurementsDetails Fair Value Measurements (Details) false false R47.htm 047 - Disclosure - Fair Value Measurements (Details 1) Sheet http://www.interceptpharma.com/role/FairValueMeasurementsDetails1 Fair Value Measurements (Details 1) false false R48.htm 048 - Disclosure - Stockholders' Equity and Preferred Stock (Details Textual) Sheet http://www.interceptpharma.com/role/StockholdersEquityAndPreferredStockDetailsTextual Stockholders' Equity and Preferred Stock (Details Textual) false false R49.htm 049 - Disclosure - 2003 Stock Incentive Plan and 2012 Stock Plan (Details) Sheet http://www.interceptpharma.com/role/StockIncentivePlanAnd2012StockPlanDetails 2003 Stock Incentive Plan and 2012 Stock Plan (Details) false false R50.htm 050 - Disclosure - 2003 Stock Incentive Plan and 2012 Stock Plan (Details 1) Sheet http://www.interceptpharma.com/role/Stockincentiveplanand2012stockplancmtorevisedetails1 2003 Stock Incentive Plan and 2012 Stock Plan (Details 1) false false R51.htm 051 - Disclosure - 2003 Stock Incentive Plan and 2012 Stock Plan (Details 2) Sheet http://www.interceptpharma.com/role/Stockincentiveplanand2012stockplandetails2 2003 Stock Incentive Plan and 2012 Stock Plan (Details 2) false false R52.htm 052 - Disclosure - 2003 Stock Incentive Plan and 2012 Stock Plan (Details 3) Sheet http://www.interceptpharma.com/role/Stockincentiveplanand2012stockplandetails3 2003 Stock Incentive Plan and 2012 Stock Plan (Details 3) false false R53.htm 053 - Disclosure - 2003 Stock Incentive Plan and 2012 Stock Plan (Details 4) Sheet http://www.interceptpharma.com/role/StockIncentivePlanAnd2012StockPlanDetails4 2003 Stock Incentive Plan and 2012 Stock Plan (Details 4) false false R54.htm 054 - Disclosure - 2003 Stock Incentive Plan and 2012 Stock Plan (Details 5) Sheet http://www.interceptpharma.com/role/StockIncentivePlanAnd2012StockPlanDetails5 2003 Stock Incentive Plan and 2012 Stock Plan (Details 5) false false R55.htm 055 - Disclosure - 2003 Stock Incentive Plan and 2012 Stock Plan (Details Textual) Sheet http://www.interceptpharma.com/role/StockIncentivePlanAnd2012StockPlandetailstextual 2003 Stock Incentive Plan and 2012 Stock Plan (Details Textual) false false R56.htm 056 - Disclosure - QTDP (Details Textual) Sheet http://www.interceptpharma.com/role/QtdpDetailsTextual QTDP (Details Textual) false false R57.htm 057 - Disclosure - Commitment and Contingencies (Details) Sheet http://www.interceptpharma.com/role/CommitmentAndContingenciesDetails Commitment and Contingencies (Details) false false R58.htm 058 - Disclosure - Commitment and Contingencies (Details Textual) Sheet http://www.interceptpharma.com/role/CommitmentAndContingenciesDetailsTextual Commitment and Contingencies (Details Textual) false false R59.htm 059 - Disclosure - Related Party Transactions (Details Textual) Sheet http://www.interceptpharma.com/role/RelatedPartyTransactionsDetailsTextual Related Party Transactions (Details Textual) false false R60.htm 060 - Disclosure - Net Loss Per Share (Details) Sheet http://www.interceptpharma.com/role/NetLossPerShareDetails Net Loss Per Share (Details) false false R61.htm 061 - Disclosure - Net Loss Per Share (Details 1) Sheet http://www.interceptpharma.com/role/NetLossPerShareDetails1 Net Loss Per Share (Details 1) false false R62.htm 062 - Disclosure - Quarterly Financial Data (unaudited) (Details) Sheet http://www.interceptpharma.com/role/QuarterlyFinancialDataUnauditedDetails Quarterly Financial Data (unaudited) (Details) false false All Reports Book All Reports Element us-gaap_CashAndCashEquivalentsAtCarryingValue had a mix of decimals attribute values: -3 0. Element us-gaap_OperatingLossCarryforwards had a mix of decimals attribute values: -6 -5. Element us-gaap_PaymentsOfStockIssuanceCosts had a mix of decimals attribute values: -6 0. Element us-gaap_ProceedsFromIssuanceOfCommonStock had a mix of decimals attribute values: -5 0. Element us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue had a mix of decimals attribute values: 0 2. 'Monetary' elements on report '040 - Disclosure - Prepaid Expenses and Other Current Assets (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '041 - Disclosure - Fixed Assets, Net (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '043 - Disclosure - Accounts Payable, Accrued Expenses and Other Liabilities (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '049 - Disclosure - 2003 Stock Incentive Plan and 2012 Stock Plan (Details)' had a mix of different decimal attribute values. 'Shares' elements on report '061 - Disclosure - Net Loss Per Share (Details 1)' had a mix of different decimal attribute values. Process Flow-Through: 002 - Statement - Consolidated Balance Sheets Process Flow-Through: Removing column 'Dec. 31, 2010' Process Flow-Through: Removing column 'Dec. 31, 2009' Process Flow-Through: Removing column 'Dec. 31, 2008' Process Flow-Through: Removing column 'Dec. 31, 2007' Process Flow-Through: Removing column 'Sep. 03, 2002' Process Flow-Through: 003 - Statement - Consolidated Balance Sheets [Parenthetical] Process Flow-Through: Removing column 'Oct. 31, 2012' Process Flow-Through: Removing column 'Aug. 31, 2012' Process Flow-Through: Removing column 'Jan. 31, 2010' Process Flow-Through: Removing column 'May 31, 2008 Series A Preferred Stock [Member]' Process Flow-Through: Removing column 'Jan. 31, 2010 Series B Preferred Stock [Member]' Process Flow-Through: 004 - Statement - Consolidated Statements of Operations and Comprehensive Loss Process Flow-Through: Removing column '3 Months Ended Dec. 31, 2012' Process Flow-Through: Removing column '3 Months Ended Sep. 30, 2012' Process Flow-Through: Removing column '3 Months Ended Jun. 30, 2012' Process Flow-Through: Removing column '3 Months Ended Mar. 31, 2012' Process Flow-Through: Removing column '3 Months Ended Dec. 31, 2011' Process Flow-Through: Removing column '3 Months Ended Sep. 30, 2011' Process Flow-Through: Removing column '3 Months Ended Jun. 30, 2011' Process Flow-Through: Removing column '3 Months Ended Mar. 31, 2011' Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2009' Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2008' Process Flow-Through: Removing column '64 Months Ended Dec. 31, 2007' Process Flow-Through: 006 - Statement - Consolidated Statements of Cash Flows Process Flow-Through: 007 - Statement - Consolidated Statements of Cash Flows [Parenthetical] icpt-20121231.xml icpt-20121231.xsd icpt-20121231_cal.xml icpt-20121231_def.xml icpt-20121231_lab.xml icpt-20121231_pre.xml true true